ConductScience.org, home

Paper29442015

Prognostic factors in patients with advanced and recurrent colorectal cancer receiving last-line chemotherapy.

Kimura M and 4 others. Pharmazie, 2018. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Prognostic factors in patients with advanced and recurrent colorectal cancer receiving last-line chemotherapy. Papers, record 29442015. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29442015

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prognostic factors in patients with advanced and recurrent colorectal cancer receiving last-line chemotherapy.
PubMed
Journal
Pharmazie
PubMed
Year
2018
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.22
iCite
Revised in PubMed
2026-01-27
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kimura MM
2Iwai MM
3Usami EE
4Teramachi HH
5Yoshimura TT

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Colorectal NeoplasmsMajor topic
Adult
Aged
Aged, 80 and over
Analgesics, Opioid
Antineoplastic Combined Chemotherapy Protocols
Cancer Pain
Disease-Free Survival
Female
Humans
Japan
Kaplan-Meier Estimate
Male
Middle Aged
Mutation
Neoplasm Recurrence, Local
Prognosis
Proto-Oncogene Proteins p21(ras)
Survival Analysis

Source PubMed

Download CSV of topics

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
40073613Routinely available inflammation biomarkers to predict stroke and mortality in atrial fibrillation.Clinics (Sao Paulo)2025https://conductscience.org/library/papers/40073613PubMed
37373912Clinical Effect of the C-Reactive Protein to Serum Albumin Ratio in Patients with Metastatic Gastric or Gastroesophageal Junction Cancer Treated with Trifluridine/Tipiracil.J Pers Med2023https://conductscience.org/library/papers/37373912PubMed
32118751The impact of pain and opioids use on survival in cancer patients: Results from a population-based cohort study and a meta-analysis.Medicine (Baltimore)2020https://conductscience.org/library/papers/32118751PubMed
32050795The signature of pharmaceutical sensitivity based on ctDNA mutation in eleven cancers.Exp Biol Med (Maywood)2020https://conductscience.org/library/papers/32050795PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
KRAS3845PubTator's text mininghttps://conductscience.org/library/genes/3845

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29442015

GET https://conductscience.org/api/papers/v1/29442015/authors